Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
CRISPR THERAPEUTICS AG (CRSP), most recent 12 months reported: revenue $13.39M, net loss $451.14M, free cash flow -$371.32M. Latest balance sheet on file: liquid cash $2.36B, total debt $586.2M, net cash $1.78B. From SEC filings. More on CRISPR THERAPEUTICS AG: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): LENZ THERAPEUTICS, INC. · X4 PHARMACEUTICALS, INC · Alpha Cognition Inc. · Alector, Inc. · Lineage Cell Therapeutics, Inc. · ELUTIA INC. · Surrozen, Inc./DE · Relay Therapeutics, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.